Document is current
Any future updates will be listed below
-
Authors
Paulissen, Jeroen Hendrikus Jacobus https://orcid.org/0000-0003-2742-9870
van Schoonhoven, Alexander Victor https://orcid.org/0000-0001-8394-3554
Olin, Emma https://orcid.org/0000-0003-1762-5851
Postma, Arjan Jacobus
Mbanya, Zacharie
Dunton, Kyle John
Postma, Maarten Jacobus https://orcid.org/0000-0002-6306-3653
van Hulst, Marinus https://orcid.org/0000-0003-3216-7246
Freriks, Roel Donald https://orcid.org/0000-0002-9458-1832
-
Funding
Funding for this research was provided by:
Universitair Medisch Centrum Groningen
Daiichi Sankyo International
AstraZeneca
- License Information
-
More Information
Article History
Received: 14 August 2024
Accepted: 11 October 2024
First Online: 12 November 2024
Declarations
:
: Jeroen Hendrikus Jacobus Paulissen, Alexander Victor van Schoonhoven, and Arjan Jacobus Postma are paid employees of Asc Academics; Emma Olin and Zacharie Mbanya are paid employees of AstraZeneca; Kyle John Dunton is a paid employee of Daiichi Sankyo International; Marinus van Hulst reports no financial interests; Maarten Jacobus Postma is advisor to Asc Academics. Roel Donald Freriks was an employee of Asc Academics at the time the research was conducted. He is currently employed by IQVIA. Asc Academics received consulting fees paid from Daiichi Sankyo International and AstraZeneca. Maarten Jacobus Postma is a non-remunerated member of the UK’s Joint Committee of Vaccination and Immunization, other authors report no non-financial interests.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
